[Protective effects of lidoflazine and mioflazine in ischemic myocardium].
Liu
G S
GS
Borgers
M
M
Xhonneux
R
R
D000818:Animals; D002118:Calcium / Q000032:analysis; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D003327:Coronary Disease / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006439:Hemodynamics; D066298:In Vitro Techniques; D008013:Lidoflazine / Q000627:therapeutic use*; D008297:Male; D009206:Myocardium / Q000473:pathology; D010879:Piperazines / Q000627:therapeutic use*; D011817:Rabbits
D002317:Cardiovascular Agents; D010879:Piperazines; C041518:mioflazine; D008013:Lidoflazine; D002118:Calcium